CPHI
China Pharma Holdings Inc
NYSE MKT: CPHI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.55
-0.16% today
Updated 2026-04-30
Market cap
$25.50M
P/E ratio
—
P/S ratio
6.15x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
China Pharma Holdings Inc (CPHI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-76.90%
Operating margin
-97.90%
ROE
-20.90%
ROA
-8.41%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $21.84M | $8.59M | 46.23% | 39.48% | 39.31% |
| 2007 | $33.19M | $12.82M | 46.91% | 36.92% | 38.63% |
| 2008 | $50.97M | $17.83M | 49.62% | 38.71% | 34.99% |
| 2009 | $61.70M | $20.23M | 41.57% | 36.65% | 32.79% |
| 2010 | $74.39M | $23.41M | 40.71% | 33.16% | 31.48% |
| 2011 | $81.17M | $19.27M | 35.71% | 27.14% | 23.74% |
| 2012 | $54.51M | $4.62M | 25.82% | 11.92% | 8.47% |
| 2013 | $32.81M | $-20.01M | 9.81% | -45.44% | -60.99% |
| 2014 | $22.13M | $-26.05M | 12.05% | -165.11% | -117.68% |
| 2015 | $20.35M | $-15.41M | 7.20% | -69.75% | -75.70% |
| 2016 | $15.57M | $-9.18M | 20.67% | -26.93% | -58.97% |
| 2017 | $13.21M | $-19.28M | 18.68% | -34.03% | -145.91% |
| 2018 | $12.33M | $-10.75M | 16.02% | -32.18% | -87.18% |
| 2019 | $10.92M | $-20.70M | 13.57% | -31.03% | -189.51% |
| 2020 | $10.87M | $-2.87M | 17.97% | -23.73% | -26.38% |
| 2021 | $9.64M | $-3.40M | 3.62% | -29.67% | -35.26% |
| 2022 | $8.10M | $-3.97M | -6.09% | -43.79% | -49.02% |
| 2023 | $7.01M | $-3.08M | -4.01% | -39.25% | -43.91% |
| 2024 | $4.53M | $-4.74M | -43.84% | -101.32% | -104.58% |
| 2025 | $4.14M | $-3.19M | -3.18% | -74.53% | -76.91% |